Early-stage trial for Parkinson’s disease therapy shows signs of promise (Initial results from phase 1 open label study)
While double-blind studies are critical to assure efficacy, a phase 1 open study shows positive results from the use of Bendaneprocel therapy to replace dopamine producing cells for those with Parkinson’s Disease. “The data from this phase 1 open label study are extremely encouraging,” said Claire Henchcliffe, a neurologist at the University of California, Irvine, who was one of the study’s principal investigators. “While this is a small open label study, meeting the study’s primary objective for safety and tolerability along with initial improvements seen in clinical outcomes represents a great step forward. The hope now is that these trends continue and translate into meaningful benefit for people with Parkinson’s disease in controlled clinical trials.” Read more CLICK TO READ THE FULL ARTICLE
To ensure we are providing accurate and timely information, we only list articles on studies that are published in peer-reviewed periodicals and provide information to help you live well with PD. To find additional papers and researchCLICK HERE
Parkinson's Association of Southwest Florida 2575 Northbrooke Plaza Drive Suite#301, Naples, FL 34119 239-417-3465 Office@ParkinsonAssociationSWFL.org Hours of Operation: Monday - Thursday 9 am - 5 pm Friday 9 am - 3 pm
Has the Parkinson's Association of Southwest Florida impacted your life? Don't forget to leave us a review on Facebookor on Google.